An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
Zafgen, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Pendlebury Research
Cardiff, New South Wales, Australia
- Australian Clinical Research Network
Maroubra, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Illawara Diabetes Service
Wollongong, New South Wales, Australia
- Q-Pharm
Herston, Queensland, Australia
- Ipswich Research Institute
Ipswich, Queensland, Australia
- Austrials
Sherwood, Queensland, Australia
- Cmax
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- St. Vincent'S Hospital
Fitzroy, Victoria, Australia
- Barwon Health
Geelong, Victoria, Australia
- Austin Health
Heidelberg West, Victoria, Australia
- Emeritus Research
Malvern East, Victoria, Australia
- Baker Idi Heart and Diabetes Institute
Melbourne, Victoria, Australia
- Keogh Institute for Medical Research
Nedlands, Western Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 31 Dec 2015
- Completion
- 31 Dec 2015
- Last update posted
- 6 Jan 2016
- Registered enrollment
- 152
- Registry id
- NCT02324491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.